Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 61

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 61
---
experienced medical officers and scientific staffs and sales and client account management personnel. There is no guarantee NewGenIvf
will be able to attract such personnel or that competition among potential employers will not result in increased salaries or other benefits.
From time to time, NewGenIvf has experienced, and NewGenIvf expects to continue to experience, difficulty in hiring and retaining employees
with appropriate qualifications. Many of the companies with which NewGenIvf competes for experienced personnel have greater resources
than NewGenIvf has. If NewGenIvf hires employees from competitors or other companies, their former employers may attempt to assert that
these employees or NewGenIvf has breached their legal obligations, resulting in a diversion of its time and resources. In addition, prospective
and existing employees often consider the value of the equity awards they receive in connection with their contribution to the company.
If the perceived value of its equity awards declines, experiences significant volatility, or increases such that prospective employees
believe there is limited upside to the value of its equity awards, it may adversely affect its ability to recruit and retain key employees.
If NewGenIvf fails to attract new personnel or fails to retain and motivate its current personnel, its business and future growth prospects
could be harmed.

Furthermore, in order to attract
and retain key personnel and employees, the compensation amounts for NewGenIvf’s executive officers may change significantly after
consummation of the Business Combination, although there are currently no agreements in place relating to any such post Business Combination
compensation arrangements. As a result, NewGenIvf’s expenses associated with the compensation may increase, which may also have
an adverse effect on its results of operations.

NewGenIvf’s Share Incentive
Plan allows NewGenIvf to enhance its ability to attract and retain exceptionally qualified individuals and agents and to encourage them
to acquire a proprietary interest in the company’s growth and performance. Competition for highly skilled personnel and agents is
often intense and NewGenIvf may incur significant costs or may not be successful in attracting, integrating, or retaining qualified personnel
and agents to fulfill NewGenIvf’s current or future needs. NewGenIvf believes that the granting of share-based awards is of significant
importance to NewGenIvf’s ability to attract and retain agents, key personnel and employees, and NewGenIvf will continue to grant
share-based awards in the future. In addition, NewGenIvf may, with the approval of its Compensation